Con esta novedad, la vacuna puede administrarse mediante inyección subcutánea en el cuello o mediante inyección in ovo

La entrada Boehringer Ingelheim recibe la autorización para añadir la vía de administración in ovo a Prevexxion® RN+HVT+IBD se publicó primero en aviNews, la revista global de avicultura.

Facebook Twitter LinkedIn WhatsApp
We use our own and third-party cookies to improve our services and technical reasons, to improve your browsing experience, to store your preferences and, optionally, to show you advertising related to your preferences by analyzing your browsing habits. We have included some configuration options that allow you to tell us exactly which cookies you prefer and which you don't. Press ACCEPT to consent to all cookies. Press CONFIGURATION to decide the options you prefer. To obtain more information about our cookies, access our Cookies Policy here: More information
Accept Decline Manage Cookies